• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Co-managing laser cataract surgery

Article

Katherine M. Mastrota, OD, offers her view on one panelist’s presentation during the special session “Refractive/Cataract Surgery: The Future Revealed” at the 90th annual SECO International meeting in Atlanta.

Associate Optometric Editor Katherine M. Mastrota, OD, offers her view on one panelist’s presentation during the special session “Refractive/Cataract Surgery: The Future Revealed” at the 90th annual SECO International meeting in Atlanta:

Former Wills Eye Hospital surgeon Tyrie Jenkins, MD, spoke about her perspective on femtosecond laser cataract surgery, the implications of laser cataract surgery and OD cataract surgery co-management as part of a panel.

Dr. Jenkins, who is based in Honolulu, is a proponent of OD/MD cataract surgery co-management. She reviewed cataract surgery from couching to what may become the standard in cataract surgery today, laser-assisted cataract surgery. Laser-assisted cataract surgery has the potential to improve refractive outcomes and reduce cataract complications by creating a precise corneal incision and capsulorhexis as well as pre-treating the natural lens for removal with less phacoemulsification power.

The femtosecond photodisruptive laser produces microscopic bubbles that have the ability to divide material at a molecular level with no heat production. Interestingly, Dr. Jenkins notes that patient adoption of laser-assisted cataract surgery, currently an upcharge, is at 45% in her practice.

Related Videos
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.